🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m

Surrogate endpoints in oncology trials remain controversial. Our latest article answers 15 common questions, addressing pitfalls and the way forward. Learn why OS and QoL should be the gold standards. bit.ly/4dOqddM #ClinicalTrials Bishal Gyawali, MD, PhD, FASCO The Lancet

GCIG INTERLACE published in The Lancet ! 8% OS benefit at 5 yrs, HR 0.6 with induction Carbo/Taxol. After Keynote-A18, there will be discussions on how to incorporate IO, but this on its own has profound implications for LMICs. Practice changing ! thelancet.com/journals/lance…

PACE-B efficacy results published in NEJM ! SBRT non-inferior to control radiotherapy for low/intermediate risk disease for biochemical control. Congrats Nicholas van As Alison Tree 💙 Prof Emma Hall and the entire #PACE team ! The Royal Marsden NHS Foundation Trust @RM_Radiotherapy nejm.org/doi/full/10.10…

Our preprint on how early career researchers can play an important role in the future of scholarly publishing is online. This is the output from a brainstorming conference in 2023 facilitated by @berlinnovation Charité BIH Innovation Charité - Universitätsmedizin Berlin Read here: doi.org/10.31219/osf.i…

And that is a wrap for the 2024 MR-Linac Consortium consortium annual meeting. Very proud of Dr Sian cooper who presented the primary endpoint of the HERMES trial The ICR Follow us on Bluesky @ICR-CTSU showing low levels of toxicity for 2 fraction MRI-guided adaptive radiotherapy for prostate cancer.

Great representation from The Royal Marsden NHS Foundation Trust at the The Royal College of Radiologists graduation ceremony today #RCRFellows

Issued in public interest

This is who @ElonMusk really is. Don’t buy a Tesla. Location: Tesla European HQ, Amsterdam.

👨‍⚕️ Resident (Akshay Dinesan ): "Sir, how should we contour the bowel for WP-SBRT in #prostatecancer? Bowel bag or loops?" 🤔 Me (thinking back to ongoing trials): "Good question… there’s no clear consensus. Let’s look at the data!" Time to get to work...TMC Radiation Oncology

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers. I have never felt so intimidated by my peers The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

Outstanding piece of work that answers an age old question for nasopharyngeal cancers ! CA: A Cancer Journal for Clinicians Wiley American Cancer Society acsjournals.onlinelibrary.wiley.com/doi/full/10.33…

Dr Steven Quay As a prostate cancer specialist, I take issue with your speculative post. It is entirely possible to have a high grade prostate cancer with a normal or even low PSA. It is also possible to have bone mets which might only have been picked up on PSMA-PET scanning.

Excited to share that our narrative review on the management of testicular cancer is now online at JCO Oncology Practice Read here: ascopubs.org/doi/10.1200/OP… Daniele Raggi Robert Huddart💙 ASCO Journal of Clinical Oncology Testicular Cancer Testicular Cancer UK Testicular Cancer Society Check One Two - The lowdown on Testicular Cancer

📘Management of testicular cancer JCO Oncology Practice ASCO 👉doi.org/10.1200/OP-25-… OncoAlert #cancer #oncology #MedX

I’m not crying, you’re crying 🥹 PSG fans’ tifo in honor of Luis Enrique’s late daughter, Xana ❤️

In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival. Full results from a phase 3 trial: nej.md/4dM6LjD

Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology Full-text authors.elsevier.com/a/1lFrI3lXQoc1… Harshani Green 💙 @harshanigreen.bsky.social Alison Tree 💙 The Royal Marsden NHS Foundation Trust The ICR Elsevier Oncology Advance

Poll for the group. When treating whole pelvis with SBRT/UHRT do you contour: David Yang Paul Nguyen Deep Chakrabarti Harshani Green 💙 @harshanigreen.bsky.social ; Alison Tree 💙 Amar Kishan Vedang Murthy Himanshu Nagar Constantinos Zamboglou Karen Hoffman, MD, MHSc, MPH